This Is The One Reason Moderna, Novavax, And Drug Stocks Slumped
Politics will matter greatly for the biotechnology and healthcare sectors. On Thursday, President-elect <a target=_blank ...
BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It.
Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...
How RFK Jr.'s war on obesity in the age of Ozempic could shake up the booming weight-loss industry
Kennedy has promised to "Make America Healthy Again" by tackling obesity with nutrition. Here's how he could rattle the ...
Cronkite News19h
COVID-19 winter surge expected to hit marginalized communities hardest, experts warn
Experts warn of an expected winter COVID-19 surge, potentially impacting marginalized communities that have faced disproportionate effects since the pandemic began. Health advocates emphasize the need ...
Hosted on MSN22h
Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential
Moderna has indicated that it expects to return to profitability by 2028, a postponement from the previously anticipated 2026 ...
Le Lézard7h
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc.(MGX) Shareholders
Levi & Korsinsky, LLP notifies investors in Metagenomi, Inc. ("Metagenomi" or the "Company") of a class action securities ...
Vermont Business Magazine5h
VDH: COVID cases plummet
Surprisingly, those who had taken the Moderna vaccine also reported a significantly higher level of anti-S1 than the ...
Stock market today: Asian shares gain, apart from in China, after Wall St regains its stride
BANGKOK (AP) — Asian shares advanced Tuesday, apart from in China, after most U.S. stocks ticked higher to recover some of ...
Moderna’s Strategic Shift and Financial Outlook Leads to Sell Rating and Lowered Price Target
Leerink Partners analyst Mani Foroohar has reiterated their bearish stance on MRNA stock, giving a Sell rating on November 14.Don't Miss our ...
How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...
Moderna initiated with a Hold at Berenberg
Berenberg analyst Harry Gillis initiated coverage of Moderna (MRNA) with a Hold rating and $42 price target. The firm says mRNA will ...
Medscape18h
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine and Commonly Administered Vaccines After Coadministration
The concomitant administration of multiple vaccines at a single clinic visit reduces the number of required visits to healthcare providers and can improve compliance with vaccine recommendations ...